Anixa Biosciences Files 8-K
Ticker: ANIX · Form: 8-K · Filed: Nov 8, 2024 · CIK: 715446
| Field | Detail |
|---|---|
| Company | Anixa Biosciences Inc (ANIX) |
| Form Type | 8-K |
| Filed Date | Nov 8, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financials
TL;DR
Anixa Biosciences dropped an 8-K on Nov 8th, check it for Reg FD and financials.
AI Summary
Anixa Biosciences, Inc. filed an 8-K on November 8, 2024, reporting on events that occurred on the same date. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as ITUS Corp and COPYTELE INC, is incorporated in Delaware and headquartered in San Jose, California.
Why It Matters
This 8-K filing provides updates on Anixa Biosciences' regulatory disclosures and financial statements, which are crucial for investors to understand the company's current status and compliance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain significant new risks or material adverse information.
Key Players & Entities
- Anixa Biosciences, Inc. (company) — Registrant
- ITUS Corp (company) — Former company name
- COPYTELE INC (company) — Former company name
- November 8, 2024 (date) — Date of report and earliest event
- Delaware (jurisdiction) — State of incorporation
- San Jose, CA (location) — Principal executive offices
FAQ
What specific events are being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text snippet.
What financial statements and exhibits are included in this filing?
The filing states that it includes Financial Statements and Exhibits, but the content of these exhibits is not detailed in the provided text.
When was Anixa Biosciences, Inc. incorporated?
Anixa Biosciences, Inc. was incorporated in Delaware.
What is the principal executive office address for Anixa Biosciences, Inc.?
The principal executive offices are located at 3150 Almaden Expressway, Suite 250, San Jose, CA 95118.
What were the previous names of Anixa Biosciences, Inc.?
The company was formerly known as ITUS Corp and COPYTELE INC.
Filing Stats: 696 words · 3 min read · ~2 pages · Grade level 11.8 · Accepted 2024-11-08 13:31:46
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share ANIX The NASDAQ Stock Mar
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 28KB
- ex99-2.htm (EX-99.2) — 1KB
- ex99-1_001.jpg (GRAPHIC) — 14KB
- ex99-2_001.jpg (GRAPHIC) — 491KB
- 0001493152-24-044224.txt ( ) — 943KB
- anix-20241108.xsd (EX-101.SCH) — 3KB
- anix-20241108_lab.xml (EX-101.LAB) — 33KB
- anix-20241108_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: November 8, 2024 ANIXA BIOSCIENCES, INC. By: /s/ Michael J. Catelani Name: Michael J. Catelani Title: President, Chief Operating Officer and Chief Financial Officer